5335-40-0 Usage
Uses
Used in Pharmaceutical Industry:
3-(METHYLSULFONYL)BENZENESULFONYLCHLORIDE is used as a key intermediate in the synthesis of sulfa drugs and other pharmaceutical compounds for its ability to introduce sulfonyl groups into organic molecules, enhancing the therapeutic properties of these compounds.
Used in Chemical Manufacturing:
In the chemical manufacturing industry, 3-(METHYLSULFONYL)BENZENESULFONYLCHLORIDE is used as a raw material for the production of dyes and pigments, contributing to the coloration and stability of various products.
Used in Specialty Chemicals Production:
3-(METHYLSULFONYL)BENZENESULFONYLCHLORIDE is utilized as a reactant in the manufacturing of specialty chemicals, where its reactivity allows for the creation of unique chemical structures with specific applications.
Safety Note:
It is crucial to handle 3-(METHYLSULFONYL)BENZENESULFONYLCHLORIDE with caution due to its strong irritant properties, which can lead to severe skin and eye irritation. Proper safety measures should be implemented during its use to minimize potential health risks.
Check Digit Verification of cas no
The CAS Registry Mumber 5335-40-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,3 and 5 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5335-40:
(6*5)+(5*3)+(4*3)+(3*5)+(2*4)+(1*0)=80
80 % 10 = 0
So 5335-40-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H7ClO4S2/c1-13(9,10)6-3-2-4-7(5-6)14(8,11)12/h2-5H,1H3
5335-40-0Relevant academic research and scientific papers
NITRIC OXIDE-RELEASING PRODRUG MOLECULE
-
Paragraph 0103, (2018/08/01)
Provided are a type of compounds that can be used for treating cardiovascular diseases and compositions containing the compounds. The compounds and the compositions can improve lipid metabolism disorders by increasing high-density lipoprotein cholesterol in blood; in addition, the compounds and the compositions can also release nitric oxide, and reduce the onset risk of cardiovascular diseases by means of relaxing blood vessels, lowering blood pressure, inhibiting platelet adhesion and aggregation and maintaining vascular tension, and thus play an important role in preventing and treating the occurrence and development of cardiovascular diseases.
NITROXYL DONORS WITH IMPROVED THERAPEUTIC INDEX
-
Paragraph 0146, (2014/08/06)
The disclosed subject matter provides N-substituted hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed subject matter provides methods of using such compounds or pharmaceutical compositions for treating heart failure.
